Search - tctmd.com

Displaying 701 - 720 of 2197

Sort: Relevancy | Date

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Daily News

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Yael L. Maxwell

December 13, 2021

News Daily News

The ‘Black Box’ of Asymptomatic, Stable, Ischemic CAD Treated With PCI

Caitlin E. Cox

December 09, 2021

News Daily News

Which PCI Operator Are You? Four Phenotypes Emerge From Big Data

Caitlin E. Cox

December 06, 2021

News Daily News

Questions Raised About Study Linking mRNA Vaccines to Increased ACS Risk

Todd Neale

December 03, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

Shelley Wood

November 30, 2021

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Todd Neale

November 15, 2021

News Conference News AHA 2021

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

Michael O'Riordan

November 15, 2021

News Conference News AHA 2021

PALACS: Posterior Left Pericardiotomy Cuts Postop AF After Cardiac Surgery

Todd Neale

November 14, 2021

News Conference News AHA 2021

External Support for Vein Grafts in CABG Doesn’t Help Patency: VEST

Yael L. Maxwell

November 14, 2021

News Daily News

Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death

L.A. McKeown

November 11, 2021

News Conference News TCT 2021

Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support

Caitlin E. Cox

November 11, 2021

News Conference News TCT 2021

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

Yael L. Maxwell

November 09, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

Presentation TCT 2021

TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes

Presenter: Pasi Karjalainen

November 06, 2021

Presentation TCT 2021

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

Presenter: IN-HO CHAE

November 06, 2021

Presentation TCT 2021

BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

Presenter: Eline Ploumen

November 06, 2021

News Conference News TCT 2021

DCBs in Coronaries? Some Good News, but More Work Needed

L.A. McKeown

November 06, 2021

News Conference News TCT 2021

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

L.A. McKeown

November 05, 2021

Presentation TCT 2021

CAD III: One-year Outcomes of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Arteries

Presenter: Jonathan Hill

November 05, 2021

Advertisement

British Medical Groups Express Concern About Inclisiran Rollout

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

The ‘Black Box’ of Asymptomatic, Stable, Ischemic CAD Treated With PCI

Which PCI Operator Are You? Four Phenotypes Emerge From Big Data

Questions Raised About Study Linking mRNA Vaccines to Increased ACS Risk

TCTMD’s Top 10 Most Popular Stories for November 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

PALACS: Posterior Left Pericardiotomy Cuts Postop AF After Cardiac Surgery

External Support for Vein Grafts in CABG Doesn’t Help Patency: VEST

Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death

Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

DCBs in Coronaries? Some Good News, but More Work Needed

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

CAD III: One-year Outcomes of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Arteries

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content